Investigation of Lipoxin A4, Annexin A1 and Interleukin-1 Beta Levels in Individuals With Periodontitis.

NCT06700161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-11-21

No results posted yet for this study

Summary

Since the researchers thought that Annexin A1, Lipoxin A4 and IL-1 Beta parameters, which have been found to be related to inflammatory conditions, may increase in periodontitis, a common inflammatory gum disease, we wanted to evaluate the changes in Annexin A1, Lipoxin A4 and IL-1 Beta levels in the Gingival Crevicular Fluid of participants with periodontitis.

Conditions

  • Peridontal Disease

Interventions

OTHER

Obtaining CGF from patients

Periodontal clinical parameters and Annexin and Lipoxin parameters in CGF will be compared between the test and control groups

Sponsors & Collaborators

  • Eda Cetin Ozdemir

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-16
Primary Completion
2024-10-31
Completion
2024-11-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06700161 on ClinicalTrials.gov